NCT00052442View on ClinicalTrials.gov

10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Lymphoma
Interventions
DRUG

pralatrexate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Spectrum Pharmaceuticals, Inc

INDUSTRY

NCT00052442 - 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter